Loading…
Reported covered position: Legislative Assistant, Rep. Bart Stupak
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Medication Therapy Management Empowerment Act of 2013
Client: WALGREEN CO · Firm: BLANK ROME GOVERNMENT RELATIONS
S. 557 and H.R. 1024 - the "Medication Therapy Management Empowerment Act" H.R. 4190 - To amend Title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
WALGREEN CO via BLANK ROME GOVERNMENT RELATIONS
2014 · fourth_quarter · 4T
Issues relating to tax reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMOKE FREE ALTERNATIVES TRADE ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · fourth_quarter · 4T
Source: Senate LDA
| WALGREEN CO |
| 3 |
| 2014 |
| BANCVUE | 2 | 2014 |
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Safeguarding America's Pharmaceuticals Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Safeguarding America's Pharmaceuticals Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Safeguarding America's Pharmaceuticals Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
School Access to Emergency Epinephrine Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
School Access to Emergency Epinephrine Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
School Access to Emergency Epinephrine Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Permanent Internet Tax Freedom Act
Client: COMCAST CORPORATION · Firm: BLANK ROME GOVERNMENT RELATIONS
Miscellaneous tax issues, including: extenders, bonus depreciation, Sec. 181 Internet Tax Freedom Act -- S. 31 and H.R. 3086
Permanent Internet Tax Freedom Act
Client: COMCAST CORPORATION · Firm: BLANK ROME GOVERNMENT RELATIONS
Miscellaneous tax issues, including: extenders, bonus depreciation, Sec. 181 Internet Tax Freedom Act -- S. 31 and H.R. 3086
Permanent Internet Tax Freedom Act
Client: COMCAST CORPORATION · Firm: BLANK ROME GOVERNMENT RELATIONS
Miscellaneous tax issues, including: extenders, bonus depreciation, Sec. 181 Internet Tax Freedom Act -- S. 31 and H.R. 3086
To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Client: WALGREEN CO · Firm: BLANK ROME GOVERNMENT RELATIONS
S. 557 and H.R. 1024 - the "Medication Therapy Management Empowerment Act" H.R. 4190 - To amend Title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Travel Promotion, Enhancement, and Modernization Act of 2014
Client: EXPEDIA, INC. · Firm: BLANK ROME GOVERNMENT RELATIONS
Consumer issues H.R. 4450, S. 2250 Travel Promotion, Enhancement, and Modernization Act
Travel Promotion, Enhancement, and Modernization Act of 2014
Client: EXPEDIA, INC. · Firm: BLANK ROME GOVERNMENT RELATIONS
Consumer issues H.R. 4450, S. 2250 Travel Promotion, Enhancement, and Modernization Act
Patients' Access to Treatments Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Patients' Access to Treatments Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Patients' Access to Treatments Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Stop Tampering of Prescription Pills Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Stop Tampering of Prescription Pills Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Stop Tampering of Prescription Pills Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Patent Abuse Reduction Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Patent Abuse Reduction Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Patent Abuse Reduction Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Issues relating to data security, cybersecurity, information technology, big data, cloud computing, federal IT procurement S.1599/H.R. 3361 USA Freedom Act
Issues relating to data security, cybersecurity, information technology, big data, cloud computing, federal IT procurement S.1599/H.R. 3361 USA Freedom Act
Patent Transparency and Improvements Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Patent Transparency and Improvements Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Patent Transparency and Improvements Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Preserve Access to Affordable Generics Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Preserve Access to Affordable Generics Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Preserve Access to Affordable Generics Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Travel Promotion, Enhancement, and Modernization Act of 2014
Client: EXPEDIA, INC. · Firm: BLANK ROME GOVERNMENT RELATIONS
Consumer issues H.R. 4450, S. 2250 Travel Promotion, Enhancement, and Modernization Act
Travel Promotion, Enhancement, and Modernization Act of 2014
Client: EXPEDIA, INC. · Firm: BLANK ROME GOVERNMENT RELATIONS
Consumer issues H.R. 4450, S. 2250 Travel Promotion, Enhancement, and Modernization Act
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Permanent Internet Tax Freedom Act of 2013
Client: COMCAST CORPORATION · Firm: BLANK ROME GOVERNMENT RELATIONS
Miscellaneous tax issues, including: extenders, bonus depreciation, Sec. 181 Internet Tax Freedom Act -- S. 31 and H.R. 3086
Permanent Internet Tax Freedom Act of 2013
Client: COMCAST CORPORATION · Firm: BLANK ROME GOVERNMENT RELATIONS
Miscellaneous tax issues, including: extenders, bonus depreciation, Sec. 181 Internet Tax Freedom Act -- S. 31 and H.R. 3086
Permanent Internet Tax Freedom Act of 2013
Client: COMCAST CORPORATION · Firm: BLANK ROME GOVERNMENT RELATIONS
Miscellaneous tax issues, including: extenders, bonus depreciation, Sec. 181 Internet Tax Freedom Act -- S. 31 and H.R. 3086
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Medication Therapy Management Empowerment Act of 2013
Client: WALGREEN CO · Firm: BLANK ROME GOVERNMENT RELATIONS
S. 557 and H.R. 1024 - the "Medication Therapy Management Empowerment Act" H.R. 4190 - To amend Title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Safe Prescribing Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Safe Prescribing Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Safe Prescribing Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Drug Supply Chain Security Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Drug Supply Chain Security Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Drug Supply Chain Security Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Pharmaceutical Quality, Security, and Accountability Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Pharmaceutical Quality, Security, and Accountability Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Pharmaceutical Quality, Security, and Accountability Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
American Taxpayer Relief Act of 2012
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
American Taxpayer Relief Act of 2012
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
American Taxpayer Relief Act of 2012
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Issues relating to the regulation of vapor products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYLAN LABORATORIES INC via BLANK ROME GOVERNMENT RELATIONS
2014 · fourth_quarter · 4T
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
General tax issues Issues related to corporate inversions
US policy with respect to India Implementing PEPFAR Stewardship and Oversight Act of 2013
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTH INDUSTRY DISTRIBUTERS ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · fourth_quarter · 4T
Issues relating to the distribution of health care products Issues relating to competitive bidding and pharmaceutical pedigree 21st Century Cures initiative; Medical device licensure legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXPEDIA, INC. via BLANK ROME GOVERNMENT RELATIONS
2014 · fourth_quarter · 4T
Issues related to the disclosure of airline fees Issues related to the disclosure of transportation fees
Consumer issues H.R. 4450, S. 2250 Travel Promotion, Enhancement, and Modernization Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMC CORP via BLANK ROME GOVERNMENT RELATIONS
2014 · fourth_quarter · 4T
Issues relating to data security, cybersecurity, information technology, big data, cloud computing, federal IT procurement S.1599/H.R. 3361 USA Freedom Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMCAST CORPORATION via BLANK ROME GOVERNMENT RELATIONS
2014 · fourth_quarter · 4T
Cybersecurity; information sharing; broadband adoption and access; online video; open internet; proposed Comcast/Time Warner Cable transaction; Local Choice
Miscellaneous tax issues, including: extenders, bonus depreciation, Sec. 181 Internet Tax Freedom Act -- S. 31 and H.R. 3086
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BANCVUE via BLANK ROME GOVERNMENT RELATIONS
2014 · fourth_quarter · 4T
Issues related to the regulation of banking products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMC CORP via BLANK ROME GOVERNMENT RELATIONS
2014 · third_quarter · Q3
Issues relating to data security, cybersecurity, information technology, big data, cloud computing, federal IT procurement S.1599/H.R. 3361 USA Freedom Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXPEDIA, INC. via BLANK ROME GOVERNMENT RELATIONS
2014 · third_quarter · Q3
Consumer issues H.R. 4450, S. 2250 Travel Promotion, Enhancement, and Modernization Act
Issues related to the disclosure of airline fees Issues related to the disclosure of transportation fees
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN CO via BLANK ROME GOVERNMENT RELATIONS
2014 · third_quarter · Q3
Issues relating to tax reform and corporate inversions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMCAST CORPORATION via BLANK ROME GOVERNMENT RELATIONS
2014 · third_quarter · Q3
Cybersecurity; information sharing; broadband adoption and access; online video; open internet; proposed Comcast/Time Warner Cable transaction; Local Choice
Miscellaneous tax issues, including: extenders, bonus depreciation, Sec. 181 Internet Tax Freedom Act -- S. 31 and H.R. 3086
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTH INDUSTRY DISTRIBUTERS ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · third_quarter · Q3
Issues relating to the distribution of health care products Issues relating to competitive bidding and pharmaceutical pedigree
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMOKE FREE ALTERNATIVES TRADE ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · third_quarter · Q3
Issues relating to the regulation of vapor products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYLAN LABORATORIES INC via BLANK ROME GOVERNMENT RELATIONS
2014 · third_quarter · Q3
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
US policy with respect to India Implementing PEPFAR Stewardship and Oversight Act of 2013
SMOKE FREE ALTERNATIVES TRADE ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · Q2
Issues relating to the regulation of vapor products
Issues related to the taxation of vapor products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN CO via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · Q2
S. 557 and H.R. 1024 - the "Medication Therapy Management Empowerment Act" H.R. 4190 - To amend Title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Issues relating to tax reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYLAN LABORATORIES INC via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · 2A
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
COMCAST CORPORATION via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · Q2
Cybersecurity; information sharing; broadband adoption and access; online video; open internet; proposed Comcast/Time Warner Cable transaction
Miscellaneous tax issues, including: extenders, bonus depreciation, Sec. 181 Internet Tax Freedom Act -- S. 31 and H.R. 3086
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMC CORP via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · Q2
Issues relating to data security, cybersecurity, information technology, big data, cloud computing, federal IT procurement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTH INDUSTRY DISTRIBUTERS ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · Q2
Issues relating to excise tax on medical devices
Issues relating to the distribution of health care products Issues relating to competitive bidding and pharmaceutical pedigree
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXPEDIA, INC. via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · Q2
Issues related to the disclosure of airline fees Issues related to the disclosure of transportation fees
Consumer issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BANCVUE via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · RR
Issues related to the regulation of banking products.
HEALTH INDUSTRY DISTRIBUTERS ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · RR
DMEPOS Competitive Bidding; Excise Tax on Medical Devices; Pharmaceutical Pedigree
MYLAN LABORATORIES INC via BLANK ROME GOVERNMENT RELATIONS
2014 · first_quarter · 1A
FY 2014 Appropriations; President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund; Generic Drug User Fees; Biosimilar User Fees; Funding for FDA; Funding for the Office of Generic Drugs; FY14 Presidential Budget Request
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYLAN LABORATORIES INC via BLANK ROME GOVERNMENT RELATIONS
2014 · first_quarter · Q1
FY 2014 Appropriations; President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund; Generic Drug User Fees; Biosimilar User Fees; Funding for FDA; Funding for the Office of Generic Drugs; FY14 Presidential Budget Request
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMOKE FREE ALTERNATIVES TRADE ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · first_quarter · Q1
Issues relating to the regulation of vapor products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
General tax issues Issues related to corporate inversions
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE